FDA Approves First-in-Class Drug for Gastric Cancer

FDA Approves First-in-Class Drug for Gastric Cancer

The FDA has approved Vyloy (zolbetuximab-clzb) as a first-line treatment of adults with locally advanced unresectable…

Continue Reading
RNT Health Insights’ gastric cancer tool gets breakthrough device designation

RNT Health Insights’ gastric cancer tool gets breakthrough device designation

RNT Health Insights’ early gastric cancer detection tool has a 96% accuracy rate. Credit: SofikoS /…

Continue Reading
4 Ways to Screen for Colon Cancer Without a Colonoscopy | Hartford HealthCare

4 Ways to Screen for Colon Cancer Without a Colonoscopy | Hartford HealthCare

<< Back May 14, 2024 If you’re dreading your next colonoscopy, you might be wondering about…

Continue Reading
Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Junction Cancer

Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Junction Cancer

A new targeted cancer treatment, given in combination with a standard chemotherapy, for adults with stomach…

Continue Reading
Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment

Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment

Astellas Pharma’s Vyloy (zolbetuximab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA)…

Continue Reading
Experts link rising throat cancer cases to HPV, oral sex

Experts link rising throat cancer cases to HPV, oral sex

Oral sex could fuel the rising number of throat cancer cases, according to health experts. UK…

Continue Reading